Company / Shareholders' Equity
AbCellera Biologics Inc. Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$966.9M
FY2025
5-year range
$10.3M / $1.2B
FY2021-FY2025
Trend
-8.4%
vs FY2024
Sector context
#50 of 213
Health Care
What the data says
AbCellera Biologics Inc.'s shareholders' equity of $967M is higher than 77% of companies in the Health Care sector (FY2025). Shareholders' Equity has fluctuated over the past 7 years, ranging from $10M in FY2021 to $1.2B in FY2023.
Based on SEC 10-K filings.
$967M in FY2025 with a 5-year CAGR of +3.1%. Top quartile in the Health Care sector.
Declined from $1.2B to $967M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +5.2%
- 5-Year CAGR
- +3.1%
- 10-Year CAGR
- -
Sector benchmark
-62.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.1%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 8.4% year-over-year.
- Ranks #50 out of 213 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $966.9M | -8.4% |
| FY2024 | $1.1B | -8.4% |
| FY2023 | $1.2B | +38.7% |
| FY2022 | $830.5M | +8000.9% |
| FY2021 | $10.3M | -98.8% |
| FY2020 | $830.5M | +8000.9% |
| FY2019 | $10.3M | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026